Keith Tennison is an accomplished commercial and market access executive with more than 27 years of leadership experience in the biopharmaceutical, healthcare, life sciences, and biotechnology industries. Throughout his distinguished career, he has built a reputation for helping organizations successfully navigate the complex path from clinical innovation to commercial success. His expertise spans rare diseases, neurology, psychiatry, specialty pharmaceuticals, drug-device combinations, digital healthcare, healthcare finance, reimbursement strategy, and commercialization, making him a highly respected executive capable of aligning scientific breakthroughs with sustainable business growth. Known for combining operational excellence with strategic vision, Keith has consistently developed innovative access strategies that improve patient outcomes while strengthening organizational performance.
Keith’s professional journey reflects a steady progression through some of the pharmaceutical industry’s most respected organizations, where he has continually expanded his leadership responsibilities while developing deep expertise in market access and commercialization. Throughout every stage of his career, he has remained focused on one central objective: ensuring that innovative therapies reach the patients who need them most. His unique understanding of healthcare reimbursement, payer dynamics, and commercialization strategy enables him to solve one of healthcare’s greatest challenges—bridging the gap between medical innovation and patient accessibility within an increasingly complex regulatory environment.
Currently serving as Vice President of Market Access for KalVista Pharmaceuticals, Keith was recruited to build and operationalize the company’s U.S. Market Access organization in preparation for the commercialization of a rare disease immunology therapy. In this executive leadership role, he oversees payer strategy, patient services, health economics and outcomes research (HEOR), pricing, trade, distribution, market access operations, and account management. His leadership has been instrumental in establishing the commercial infrastructure necessary to support launch readiness while positioning the organization for long-term success. As a key member of the commercial leadership team, Keith collaborates closely with executive leadership to shape market access strategy, reimbursement planning, and patient engagement initiatives that create lasting enterprise value.
Before joining KalVista Pharmaceuticals, Keith served as Head of U.S. Market Access Strategy for Epilepsy and Rare Syndromes at UCB, reporting directly to the U.S. President. In this highly strategic position, he led comprehensive market access initiatives supporting multiple specialty portfolios while directing pricing strategy, contracting, specialty pharmacy networks, patient affordability programs, channel strategy, and value-based healthcare initiatives. His work extended beyond traditional market access functions, contributing significantly to launch planning, commercial due diligence, asset integration, and cross-functional collaboration with Medical Affairs, Marketing, Clinical Development, Global Market Access, and Health Economics teams. His ability to integrate commercial strategy across organizational functions consistently strengthened product launches and improved market performance.
Keith previously spent more than a decade with Sunovion Pharmaceuticals, where he demonstrated exceptional leadership through a series of progressively advanced positions, including Director of Health System Accounts, Director of Business Operations, Regional Business Manager, and Therapeutic Specialist. During his tenure, he successfully supported multiple commercial launches while developing payer strategies, health system partnerships, value propositions, customer engagement initiatives, business planning, CRM optimization, analytics, sales enablement, and strategic account management programs. His work with integrated delivery networks, accountable care organizations, providers, specialty pharmacies, and payer organizations helped strengthen product access while improving collaboration across the healthcare ecosystem. His consistent performance and ability to deliver measurable commercial results earned him numerous promotions and increasing executive responsibility.
Keith’s pharmaceutical foundation was established during a highly successful thirteen-year career with Pfizer, where he steadily advanced through leadership positions supporting psychiatry, neurology, antibiotics, and specialty pharmaceutical portfolios. Beginning in primary care sales during a significant expansion initiative, he quickly progressed into increasingly senior roles involving specialty sales, institutional healthcare, Department of Defense healthcare programs, field operations, training, strategic account management, sales leadership, and launch execution. These experiences provided him with a comprehensive understanding of every stage of pharmaceutical commercialization while developing the executive leadership capabilities that continue to distinguish his career.
Throughout his career, Keith has become recognized as a subject matter expert in healthcare reimbursement and market access strategy—an area of healthcare that often operates behind the scenes but serves as one of the most critical determinants of commercial success. His expertise includes payer engagement, pricing strategy, health economics and outcomes research, specialty pharmacy, trade and distribution, integrated delivery networks, value-based contracting, healthcare finance, and patient services. Having worked extensively with national payers, pharmacy benefit managers, provider systems, and healthcare organizations, he possesses an uncommon understanding of the financial, operational, and regulatory complexities that influence patient access to innovative therapies. This specialized knowledge has enabled organizations to reduce risk, optimize reimbursement pathways, and successfully commercialize highly specialized products.
Keith’s educational background reflects the combination of scientific knowledge and business acumen that defines his leadership style. He earned a Bachelor of Science in Biology from Lamar University before completing a Master of Business Administration in Healthcare Management from the University of Phoenix. His commitment to professional excellence is further demonstrated through earning both the Certified Healthcare Financial Professional (CHFP) and Certified Specialist in Managed Care (CSMC) designations. He also maintains active involvement with the Healthcare Financial Management Association (HFMA), the American College of Healthcare Executives (ACHE), and the Strategic Account Management Association, reinforcing his dedication to continuous learning and industry engagement.
Beyond his executive accomplishments, Keith is deeply motivated by improving healthcare through thoughtful leadership and strategic governance. Having worked extensively alongside executive leadership teams and corporate boards, he recognizes the significant value experienced commercialization leaders can bring to boardroom discussions. Throughout his career, he observed that many organizations lacked directors with practical expertise in healthcare reimbursement, pharmaceutical commercialization, and market access strategy. He believes this experience gap can expose organizations to unnecessary commercial risk, regulatory challenges, and missed growth opportunities. His desire to serve on corporate boards stems from a passion for helping leadership teams make informed strategic decisions while providing practical guidance rooted in decades of real-world commercial experience.
Keith approaches leadership with humility, collaboration, and a genuine commitment to developing organizations that improve patient outcomes while delivering sustainable financial performance. His ability to translate highly technical reimbursement, commercialization, and healthcare finance concepts into clear business strategies has earned him the trust of executive leadership, cross-functional teams, and external stakeholders alike. As healthcare continues to evolve through scientific innovation, value-based care, digital transformation, and increasingly complex reimbursement environments, Keith remains committed to helping organizations successfully navigate change while ensuring groundbreaking therapies become accessible to the patients whose lives depend upon them.
Character:
Keith demonstrates integrity, accountability, and an unwavering commitment to improving healthcare through patient-centered leadership. He builds trusted relationships by leading with humility, collaboration, and a genuine desire to help organizations achieve meaningful and lasting success.
Knowledge:
He possesses extensive expertise in pharmaceutical commercialization, healthcare reimbursement, market access, pricing strategy, health economics, specialty pharmacy, and payer engagement developed through more than twenty-seven years of executive leadership. His broad understanding of both scientific innovation and commercial execution enables him to guide organizations through highly complex healthcare environments with confidence and precision.
Strategic:
Keith consistently develops forward-looking commercialization strategies that balance innovation, financial performance, patient access, and long-term organizational growth. His ability to anticipate reimbursement challenges and create scalable market access solutions allows organizations to successfully launch therapies while minimizing commercial risk.
Communication:
Exceling at translating complex healthcare policy, reimbursement, and commercialization issues into practical strategies that executive teams and corporate boards can confidently evaluate and implement. His collaborative communication style fosters alignment across diverse stakeholders while building consensus around critical strategic initiatives.
